FindTrial
Sign In

A phase 2a study of M520102 in atopic dermatitis patients

A phase 2a study of M520102 in atopic dermatitis patients

Status
Unknown
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080221901
Enrollment
Unknown
Registered
2012-09-04
Start date
2012-09-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atopic dermatitis

Interventions

investigational material(s) Generic name etc : M520102 INN of investigational material : Therapeutic category code : 269 Other agents for epidermis Dosage and Administration for Investigational mater

Sponsors

Maruho Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients diagnosed with atopic dermatitis Outpatient

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Eczema area and severity, Pruritus—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026